Renaissance of glucocorticoids in critical care in the era of COVID-19: ten urging questions

The 40-year-old experience with glucocorticosteroids (GCs) in the context of severe infections is complex and troublesome. Recently, however, a clear indication for GCs in severe COVID-19 has been established. This may constitute a harbinger of a wider use of GCs in critical illnesses. A fundamental...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkler, Martin S., Osuchowski, Marcin F., Payen, Didier, Torres, Antoni, Dickel, Steffen, Skirecki, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547674/
https://www.ncbi.nlm.nih.gov/pubmed/36209188
http://dx.doi.org/10.1186/s13054-022-04185-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547674/
https://www.ncbi.nlm.nih.gov/pubmed/36209188
http://dx.doi.org/10.1186/s13054-022-04185-9

Ejemplares similares